Literature DB >> 12085230

Cre-loxP chromosome engineering of a targeted deletion in the mouse corresponding to the 3p21.3 region of homozygous loss in human tumours.

Andrew J H Smith1, Jian Xian, Melville Richardson, Karen A Johnstone, Pamela H Rabbitts.   

Abstract

Chromosomal deletions are a common feature of epithelial tumours and when further defined by homozygous deletions, are often the location of tumour suppressor genes. Deletions within the short arm of chromosome 3 occur very frequently in human carcinomas: a minimal region of loss at 3p21.3 (the Luca) region has been defined by overlapping homozygous deletions in lung and breast cancer cell lines. Using a rapid strategy for Cre-loxP chromosome engineering, a deletion of approximately 370 kb was created in the mouse germline corresponding to the deleted region at 3p21.3. The deletion when homozygous is embryonic lethal. Heterozygotes develop normally despite being haplo-insufficient for twelve genes including the candidate tumour suppressor gene Rassf1. Because damage to 3p21.3 often occurs very early in the sequence of genetic changes that lead to malignancy, particularly in lung and breast cancer, further genetic damage to these mice will provide the opportunity to model multi-step tumorigenesis of these tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085230     DOI: 10.1038/sj.onc.1205530

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

Review 2.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

3.  A new deletion refines the boundaries of the murine Prader-Willi syndrome imprinting center.

Authors:  Amanda J Dubose; Emily Y Smith; Thomas P Yang; Karen A Johnstone; James L Resnick
Journal:  Hum Mol Genet       Date:  2011-06-09       Impact factor: 6.150

4.  Controlled somatic and germline copy number variation in the mouse model.

Authors:  Yann Hérault; Arnaud Duchon; Damien Maréchal; Matthieu Raveau; Patricia L Pereira; Emilie Dalloneau; Véronique Brault
Journal:  Curr Genomics       Date:  2010-09       Impact factor: 2.236

5.  Chromosomal manipulation by site-specific recombinases and fluorescent protein-based vectors.

Authors:  Munehiro Uemura; Youko Niwa; Naoki Kakazu; Noritaka Adachi; Kazuo Kinoshita
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 6.  Genetically modified mouse models in cancer studies.

Authors:  Javier Santos; Pablo Fernández-Navarro; María Villa-Morales; Laura González-Sánchez; José Fernández-Piqueras
Journal:  Clin Transl Oncol       Date:  2008-12       Impact factor: 3.405

7.  Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.

Authors:  David Garrick; Jackie A Sharpe; Ruth Arkell; Lorraine Dobbie; Andrew J H Smith; William G Wood; Douglas R Higgs; Richard J Gibbons
Journal:  PLoS Genet       Date:  2006-04-21       Impact factor: 5.917

Review 8.  Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization.

Authors:  Véronique Brault; Patricia Pereira; Arnaud Duchon; Yann Hérault
Journal:  PLoS Genet       Date:  2006-07       Impact factor: 5.917

Review 9.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

Review 10.  The Ras-association domain family (RASSF) members and their role in human tumourigenesis.

Authors:  Louise van der Weyden; David J Adams
Journal:  Biochim Biophys Acta       Date:  2007-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.